leisure time -WSS

leisure time

author：Wikipedia 2025-10-02 22:24:40 - browse：373

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： House panel to mark up pandemic

hotspot

focus

WSS

More doctors should go into startup world

Why Titanic fascinates society, still drawing tours to the wreckage

Titanic submersible: What a 'catastrophic implosion' means and what officials found

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Drinking water from half of US faucets contains PFAS: Study

Sanofi CEO defends move to abandon profit guidance, boost research

focus

leisure time

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Activists slam private health insurers over coverage restrictions

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

ChatGPT in medicine: STAT answers readers' burning questions

Masked men burn a market in a Mexican city plagued by gang violence, killing 9 people

Jerome Adams on the need for new antivirals for Covid

HPV cancer vaccine study demonstrates efficacy

Medicare details structure of new drug price negotiation program

Extreme heat events are a public health emergency

entertainment

Sanofi CEO defends move to abandon profit guidance, boost research

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

With fresh data, a dynamic duo powers Eli Lilly to new heights

Victims of gun violence feel impacts long after bullet wound

Abortion clinic in Cancun will cater to Americans

Sen. Bill Cassidy on how to lower drug prices

explore

hotspot

focus

Wikipedia